Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa H Butterfield

Showing results (141-150 of 176) with videos related to

Pageof 18
Sort By:
Journal of Translational Medicine|August 21, 2019
First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cellsBoris R Minev, Elliot Lander, John F Feller, et al.
Journal for Immunotherapy of Cancer|May 19, 2017
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapySacha Gnjatic, Vincenzo Bronte, Laura Rosa Brunet, et al.
Journal of Translational Medicine|June 6, 2022
Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to malesMariam Saad, Sandra J Lee, Aik Choon Tan, et al.
Journal for Immunotherapy of Cancer|July 13, 2018
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)Paolo A Ascierto, James Brugarolas, Luigi Buonaguro, et al.
Journal of Translational Medicine|November 7, 2012
A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapiesAdrian Bot, Mark Ahn, Marnix Bosch, et al.
Cancers|February 10, 2024
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and BeyondSurya Pandey, Meghan E Cholak, Rishita Yadali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2025
Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-Risk MelanomaAhmad A Tarhini, Alyssa Obermayer, Sandra J Lee, et al.
Journal of Translational Medicine|November 5, 2017
The need for a network to establish and validate predictive biomarkers in cancer immunotherapyGiuseppe V Masucci, Alessandra Cesano, Alexander Eggermont, et al.
Journal of Translational Medicine|January 7, 2021
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge" (December 4th-5th, 2019, Naples, Italy)Paolo A Ascierto, Lisa H Butterfield, Katie Campbell, et al.
Journal for Immunotherapy of Cancer|January 21, 2016
Novel technologies and emerging biomarkers for personalized cancer immunotherapyJianda Yuan, Priti S Hegde, Raphael Clynes, et al.
Pageof 18

Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
Journal of Translational Medicine|August 21, 2019
First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cellsBoris R Minev, Elliot Lander, John F Feller, et al.
Journal for Immunotherapy of Cancer|May 19, 2017
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapySacha Gnjatic, Vincenzo Bronte, Laura Rosa Brunet, et al.
Journal of Translational Medicine|June 6, 2022
Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to malesMariam Saad, Sandra J Lee, Aik Choon Tan, et al.
Journal for Immunotherapy of Cancer|July 13, 2018
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)Paolo A Ascierto, James Brugarolas, Luigi Buonaguro, et al.
Journal of Translational Medicine|November 7, 2012
A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapiesAdrian Bot, Mark Ahn, Marnix Bosch, et al.
Cancers|February 10, 2024
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and BeyondSurya Pandey, Meghan E Cholak, Rishita Yadali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2025
Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-Risk MelanomaAhmad A Tarhini, Alyssa Obermayer, Sandra J Lee, et al.
Journal of Translational Medicine|November 5, 2017
The need for a network to establish and validate predictive biomarkers in cancer immunotherapyGiuseppe V Masucci, Alessandra Cesano, Alexander Eggermont, et al.
Journal of Translational Medicine|January 7, 2021
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge" (December 4th-5th, 2019, Naples, Italy)Paolo A Ascierto, Lisa H Butterfield, Katie Campbell, et al.
Journal for Immunotherapy of Cancer|January 21, 2016
Novel technologies and emerging biomarkers for personalized cancer immunotherapyJianda Yuan, Priti S Hegde, Raphael Clynes, et al.
Pageof 18